Pioglitazone Hydrochloride Patent Expiration

Pioglitazone Hydrochloride is Used for managing and improving glycemic control in patients with type 2 diabetes. It was first introduced by Takeda Pharmaceuticals Usa Inc in its drug Actos on Jul 15, 1999. 15 different companies have introduced drugs containing Pioglitazone Hydrochloride.


Pioglitazone Hydrochloride Patents

Given below is the list of patents protecting Pioglitazone Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Actos US6303640 Pharmaceutical composition Aug 09, 2016

(Expired)

Takeda Pharms Usa
Actos US5965584 Pharmaceutical composition Jun 19, 2016

(Expired)

Takeda Pharms Usa
Actos US6150383 Pharmaceutical composition Jun 19, 2016

(Expired)

Takeda Pharms Usa
Actos US6150384 Pharmaceutical composition Jun 19, 2016

(Expired)

Takeda Pharms Usa
Actos US6166042 Pharmaceutical composition Jun 19, 2016

(Expired)

Takeda Pharms Usa
Actos US6166043 Pharmaceutical composition Jun 19, 2016

(Expired)

Takeda Pharms Usa
Actos US6172090 Pharmaceutical composition Jun 19, 2016

(Expired)

Takeda Pharms Usa
Actos US6211205 Pharmaceutical composition Jun 19, 2016

(Expired)

Takeda Pharms Usa
Actos US6271243 Pharmaceutical composition Jun 19, 2016

(Expired)

Takeda Pharms Usa
Actos US6329404 Pharmaceutical composition Jun 19, 2016

(Expired)

Takeda Pharms Usa



Pioglitazone Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Pioglitazone Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Pioglitazone Hydrochloride. The first generic version for Pioglitazone Hydrochloride was by Norvium Bioscience Llc and was approved on Aug 17, 2012. And the latest generic version is by Corepharma Llc and was approved on Jan 22, 2021.

Given below is the list of companies who have filed for Pioglitazone Hydrochloride generic, along with the locations of their manufacturing plants worldwide.


1. ACCORD HLTHCARE

Accord Healthcare Inc has filed for 3 different strengths of generic version for Pioglitazone Hydrochloride. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 15MG BASE

tablet Prescription ORAL AB Feb 13, 2013
EQ 30MG BASE

tablet Prescription ORAL AB Feb 13, 2013
EQ 45MG BASE

tablet Prescription ORAL AB Feb 13, 2013





2. ANNORA PHARMA

Annora Pharma Private Ltd has filed for 3 different strengths of generic version for Pioglitazone Hydrochloride. Given below are the details of the strengths of this generic introduced by Annora Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 30MG BASE

tablet Prescription ORAL AB Apr 7, 2014
EQ 15MG BASE

tablet Prescription ORAL AB Apr 7, 2014
EQ 45MG BASE

tablet Prescription ORAL AB Apr 7, 2014


Manufacturing Plant Locations
New

Annora Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Annora Pharma as present at those locations.

Country City Firm Name
India
Hyderabad Annora Pharma Private Limited





3. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Pioglitazone Hydrochloride. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 15MG BASE

tablet Prescription ORAL AB Feb 13, 2013
EQ 30MG BASE

tablet Prescription ORAL AB Feb 13, 2013
EQ 45MG BASE

tablet Prescription ORAL AB Feb 13, 2013


Manufacturing Plant Locations
New

Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.

Country City Firm Name
India
Medchal Aurobindo Pharma Ltd





4. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 3 different strengths of generic version for Pioglitazone Hydrochloride. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 15MG BASE

tablet Discontinued ORAL N/A Mar 12, 2013
EQ 30MG BASE

tablet Discontinued ORAL N/A Mar 12, 2013
EQ 45MG BASE

tablet Discontinued ORAL N/A Mar 12, 2013





5. COREPHARMA

Corepharma Llc has filed for 3 different strengths of generic version for Pioglitazone Hydrochloride. Given below are the details of the strengths of this generic introduced by Corepharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 30MG BASE

tablet Prescription ORAL AB Jan 22, 2021
EQ 15MG BASE

tablet Prescription ORAL AB Jan 22, 2021
EQ 45MG BASE

tablet Prescription ORAL AB Jan 22, 2021


Manufacturing Plant Locations
New

Corepharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Corepharma as present at those locations.

Country City Firm Name
United States
Middlesex CorePharma, LLC





6. MACLEODS PHARMS LTD

Macleods Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Pioglitazone Hydrochloride. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 30MG BASE

tablet Prescription ORAL AB Feb 6, 2013
EQ 15MG BASE

tablet Prescription ORAL AB Feb 6, 2013
EQ 45MG BASE

tablet Prescription ORAL AB Feb 6, 2013





7. NORVIUM BIOSCIENCE

Norvium Bioscience Llc has filed for 3 different strengths of generic version for Pioglitazone Hydrochloride. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 15MG BASE

tablet Discontinued ORAL N/A Aug 17, 2012
EQ 30MG BASE

tablet Discontinued ORAL N/A Aug 17, 2012
EQ 45MG BASE

tablet Discontinued ORAL N/A Aug 17, 2012





8. NOSTRUM LABS INC

Nostrum Laboratories Inc has filed for 3 different strengths of generic version for Pioglitazone Hydrochloride. Given below are the details of the strengths of this generic introduced by Nostrum Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 15MG BASE

tablet Discontinued ORAL N/A Feb 13, 2013
EQ 30MG BASE

tablet Discontinued ORAL N/A Feb 13, 2013
EQ 45MG BASE

tablet Discontinued ORAL N/A Feb 13, 2013





9. PRINSTON INC

Prinston Pharmaceutical Inc has filed for 3 different strengths of generic version for Pioglitazone Hydrochloride. Given below are the details of the strengths of this generic introduced by Prinston Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 45MG BASE

tablet Prescription ORAL AB Apr 17, 2018
EQ 15MG BASE

tablet Prescription ORAL AB Apr 17, 2018
EQ 30MG BASE

tablet Prescription ORAL AB Apr 17, 2018





10. PURACAP PHARM LLC

Puracap Pharmaceutical Llc has filed for 3 different strengths of generic version for Pioglitazone Hydrochloride. Given below are the details of the strengths of this generic introduced by Puracap Pharm Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 30MG BASE

tablet Prescription ORAL AB Oct 6, 2017
EQ 45MG BASE

tablet Prescription ORAL AB Oct 6, 2017
EQ 15MG BASE

tablet Prescription ORAL AB Oct 6, 2017





11. SANDOZ

Sandoz Inc has filed for 3 different strengths of generic version for Pioglitazone Hydrochloride. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 15MG BASE

tablet Prescription ORAL AB Feb 13, 2013
EQ 30MG BASE

tablet Prescription ORAL AB Feb 13, 2013
EQ 45MG BASE

tablet Prescription ORAL AB Feb 13, 2013


Manufacturing Plant Locations
New

Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.

Country City Firm Name
Austria
Kundl Sandoz GmbH
Langkampfen Sandoz GmbH
United States
Princeton Sandoz Inc
East Hanover Sandoz Incorporated
Spain
Palafolls Sandoz Industrial Products, S.A.
Les Franqueses Del Valles Sandoz Industrial Products S.A.
India
Navi Mumbai Sandoz Private Limited





12. TEVA PHARMS USA

Teva Pharmaceuticals Usa has filed for 3 different strengths of generic version for Pioglitazone Hydrochloride. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 30MG BASE

tablet Prescription ORAL AB Jan 10, 2014
EQ 15MG BASE

tablet Prescription ORAL AB Jan 10, 2014
EQ 45MG BASE

tablet Prescription ORAL AB Jan 10, 2014





13. TORRENT PHARMS LTD

Torrent Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Pioglitazone Hydrochloride. Given below are the details of the strengths of this generic introduced by Torrent Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 15MG BASE

tablet Discontinued ORAL N/A Feb 13, 2013
EQ 30MG BASE

tablet Discontinued ORAL N/A Feb 13, 2013
EQ 45MG BASE

tablet Discontinued ORAL N/A Feb 13, 2013





14. ZYDUS PHARMS USA INC

Zydus Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Pioglitazone Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus Pharms Usa Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 15MG BASE

tablet Prescription ORAL AB Feb 13, 2013
EQ 30MG BASE

tablet Prescription ORAL AB Feb 13, 2013
EQ 45MG BASE

tablet Prescription ORAL AB Feb 13, 2013